본문 바로가기
KERD
논문KCI 등재

Review of a novel disease entity, immunoglobulin G4-related disease

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류치의학

초록

Immunoglobulin G4 (IgG4)-related dacryoadenitis and sialoadenitis (IgG4-DS) are part of a multiorgan fibroinflammatory condition of unknown etiology termed IgG4-related disease (IgG4-RD), which has been recognized as a single diagnostic entity for less than 15 years. Histopathologic examination is critical for diagnosis of IgG4-RD. CD4+ T and B cells, including IgG4-expressing plasma cells, constitute the major inflammatory cell populations in IgG4-RD and are thought to cause organ damage and tissue fibrosis. Patients with IgG4-RD who have active, untreated disease exhibit significant increase of IgG4-secreting plasmablasts in the blood. Considerable insight into the immunologic mechanisms of IgG4-RD has been achieved in the last decade using novel molecular biology approaches, including next-generation and single-cell RNA sequencing. Exploring the in-teractions between CD4+ T cells and B lineage cells is critical for understanding the pathophysiology of IgG4-RD. Establishment of pathogenic T cell clones and identification of antigens specific to these clones constitutes the first steps in determining the pathogenesis of the disease. Herein, the clini-cal features and mechanistic insights regarding pathogenesis of IgG4-RD were reviewed.

Abstract

Immunoglobulin G4 (IgG4)-related dacryoadenitis and sialoadenitis (IgG4-DS) are part of a multiorgan fibroinflammatory condition of unknown etiology termed IgG4-related disease (IgG4-RD), which has been recognized as a single diagnostic entity for less than 15 years. Histopathologic examination is critical for diagnosis of IgG4-RD. CD4+ T and B cells, including IgG4-expressing plasma cells, constitute the major inflammatory cell populations in IgG4-RD and are thought to cause organ damage and tissue fibrosis. Patients with IgG4-RD who have active, untreated disease exhibit significant increase of IgG4-secreting plasmablasts in the blood. Considerable insight into the immunologic mechanisms of IgG4-RD has been achieved in the last decade using novel molecular biology approaches, including next-generation and single-cell RNA sequencing. Exploring the in-teractions between CD4+ T cells and B lineage cells is critical for understanding the pathophysiology of IgG4-RD. Establishment of pathogenic T cell clones and identification of antigens specific to these clones constitutes the first steps in determining the pathogenesis of the disease. Herein, the clini-cal features and mechanistic insights regarding pathogenesis of IgG4-RD were reviewed.

참고문헌 (75)

  1. Kamisawa T, "IgG4-related disease", Lancet, 385, pp.1460~1471 (2015)
  2. Mahajan VS, "IgG4-related disease", Annu Rev Pathol, 9, pp.315~347 (2014)
  3. Furukawa S, "Clinical relevance of Küttner tumour and IgG4-related dacryoadenitis and sialoadenitis", Oral Dis, 21, pp.257~262 (2015)
  4. Deshpande V, "Consensus statement on the pathology of IgG4-related disease", Mod Pathol, 25, pp.1181~1192 (2012)
  5. Khosroshahi A, "International consensus guidance statement on the management and treatment of IgG4-related disease", Arthritis Rheumatol, 67, pp.1688~1699 (2015)
  6. Wallace ZS, "Clinical phenotypes of IgG4-related disease : an analysis of two international cross-sectional cohorts", Ann Rheum Dis, 78, pp.406~412 (2019)
  7. Shimizu M, "Effectiveness of imaging modalities for screening IgG4-related dacryoadenitis and sialadenitis(Mikulicz's disease)and for differentiating it from Sjögren's syndrome(SS), with an emphasis on sonography", Arthritis Res Ther, 17, pp.223~ (2015)
  8. Sakamoto M, "The diagnostic utility of submandibular gland sonography and labial salivary gland biopsy in IgG4-related dacryoadenitis and sialadenitis : Its potential application to the diagnostic criteria", Mod Rheumatol (2019)[DOI]
  9. Maehara T, "Clinical features and mechanistic insights regarding IgG4-related dacryoadenitis and sialoadenitis : a review", Int J Oral Maxillofac Surg, 48, pp.908~916 (2019)
  10. Umehara H, "Current approach to the diagnosis of IgG4-related disease-combination of comprehensive diagnostic and organ-specific criteria", Mod Rheumatol, 27, pp.381~391 (2017)
  11. Li W, "Clinicopathological characteristics of immunoglobulin G4-related sialadenitis", Arthritis Res Ther, 17, pp.186~ (2015)
  12. Moriyama M, "The diagnostic utility of biopsies from the submandibular and labial salivary glands in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz's disease", Int J Oral Maxillofac Surg, 43, pp.1276~1281 (2014)
  13. Kawa S, "HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population", Gastroenterology, 122, pp.1264~1269 (2002)
  14. Terao C, "IgG4-related disease in the Japanese population: a genome-wide association study", Lancet Rheumatol, 1, pp.PE14~PE22 (2019)
  15. Strehl JD, "Numerous IgG4-positive plasma cells are ubiquitous in diverse localised non-specific chronic inflammatory conditions and need to be distinguished from IgG4-related systemic disorders", J Clin Pathol, 64, pp.237~243 (2011)
  16. Bruhns P, "Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses", Blood, 113, pp.3716~3725 (2009)
  17. Carruthers MN, "The diagnostic utility of serum IgG4 concentrations in IgG4-related disease", Ann Rheum Dis, 74, pp.14~18 (2015)
  18. Maehara T, "IgG4-related disease -mechanistic insights from both clinical and immunologic understanding of this condition", Nihon Rinsho Meneki Gakkai Kaishi, 40, pp.206~212 (2017)
  19. Mattoo H, "Clonally expanded cytotoxic CD4+ T cells and the pathogenesis of IgG4-related disease", Autoimmunity, 50, pp.19~24 (2017)
  20. Mattoo H, "Clonal expansion of CD4(+)cytotoxic T lymphocytes in patients with IgG4-related disease", J Allergy Clin Immunol, 138, pp.825~838 (2016)
  21. Mattoo H, "De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease", J Allergy Clin Immunol, 134, pp.679~687 (2014)
  22. Haldar D, "Deciphering the biology of IgG4-related disease: specific antigens and disease?", Gut, 67, pp.602~605 (2018)
  23. Carruthers MN, "Rituximab for IgG4-related disease : a prospective, open-label trial", Ann Rheum Dis, 74, pp.1171~1177 (2015)
  24. Della-Torre E, "B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease", Ann Rheum Dis, 74, pp.2236~2243 (2015)
  25. Tanaka A, "Th2 and regulatory immune reactions contribute to IgG4 production and the initiation of Mikulicz disease", Arthritis Rheum, 64, pp.254~263 (2012)
  26. Maehara T, "Lesional CD4+ IFN-γ+ cytotoxic T lymphocytes in IgG4-related dacryoadenitis and sialoadenitis", Ann Rheum Dis, 76, pp.377~385 (2017)
  27. Tian Y, "Cytotoxic CD4 T cells : differentiation, function, and application to dengue virus infection", Front Immunol, 7, pp.531~ (2016)
  28. Wallace ZS, "Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations", Ann Rheum Dis, 74, pp.190~195 (2015)
  29. Della-Torre E, "A CD8α-subset of CD4+SLAMF7+cytotoxic T cells is expanded in patients with IgG4-related disease and decreases following glucocorticoid treatment", Arthritis Rheumatol, 70, pp.1133~1143 (2018)
  30. Pillai S, "B cells and autoimmunity", Curr Opin Immunol, 23, pp.721~731 (2011)
  31. Maehara T, "Pathogenesis of IgG4-related disease : a critical review", Odontology, 107, pp.127~132 (2019)
  32. Crotty S, "Follicular helper CD4 T cells(TFH)", Annu Rev Immunol, 29, pp.621~663 (2011)
  33. Akiyama M, "Number of circulating follicular helper 2 T cells correlates with IgG4 and interleukin-4 levels and plasmablast numbers in IgG4-related disease", Arthritis Rheumatol, 67, pp.2476~2481 (2015)
  34. Akiyama M, "Enhanced IgG4 production by follicular helper 2 T cells and the involvement of follicular helper 1 T cells in the pathogenesis of IgG4-related disease", Arthritis Res Ther, 18, pp.167~ (2016)
  35. Grados A, "T cell polarization toward TH2", TFH2 and TH17, Front Immunol, pp.2017, 8[DOI]
  36. Du H, "Prohibitin is involved in patients with IgG4 related disease", PLoS One, 10, pp.e0125331~ (2015)
  37. Hubers LM, "Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease", Gut, 67, pp.728~735 (2018)
  38. Shiokawa M, "Laminin 511 is a target antigen in autoimmune pancreatitis", Sci Transl Med, 10 (2018)
  39. Liu H, "Disease severity is linked to an increase in autoantibody diversity in IgG4-related disease", Arthritis Rheumatol (2019)[DOI]
  40. Tsuboi H, "DNA microarray analysis of labial salivary glands in IgG4-related disease : comparison with Sjögren's syndrome", Arthritis Rheumatol, 66, pp.2892~2899 (2014)
  41. Tsuboi H, "Analysis of IgG4 class switch-related molecules in IgG4-related disease", Arthritis Res Ther, 14, pp.R171~ (2012)
  42. Furukawa S, "Interleukin-33 produced by M2 macrophages and other immune cells contributes to Th2 immune reaction of IgG4-related disease", Sci Rep, 7, pp.42413~ (2017)
  43. Watanabe T, "Involvement of activation of toll-like receptors and nucleotide-binding oligomerization domain-like receptors in enhanced IgG4 responses in autoimmune pancreatitis", Arthritis Rheum, 64, pp.914~924 (2012)
  44. Watanabe T, "Toll-like receptor activation in basophils contributes to the development of IgG4-related disease", J Gastroenterol, 48, pp.247~253 (2013)
  45. Ishiguro N, "Activated M2 macrophages contribute to the pathogenesis of IgG4-related disease via toll-like receptor 7", interleukin-33 signaling, 2020, pp.72, 166~178
  46. Kamisawa T, "Standard steroid treatment for autoimmune pancreatitis", Gut, 58, pp.1504~1507 (2009)
  47. Masaki Y, "A multicenter phase II prospective clinical trial of glucocorticoid for patients with untreated IgG4-related disease", Mod Rheumatol, 27, pp.849~854 (2017)
  48. Hong X, "Treatment of immunoglobulin G4-related sialadenitis : outcomes of glucocorticoid therapy combined with steroid-sparing agents", Arthritis Res Ther, 20, pp.12~ (2018)
  49. Masamune A, "Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis", Gut, 66, pp.487~494 (2017)
  50. Shimosegawa T, "International consensus diagnostic criteria for autoimmune pancreatitis : guidelines of the International Association of Pancreatology", Pancreas, 40, pp.352~358 (2011)
  51. Moriyama M, "Clinical characteristics of Mikulicz's disease as an IgG4-related disease", Clin Oral Investig, 17, pp.1995~2002 (2013)
  52. Maehara T, "The expansion in lymphoid organs of IL-4+ BATF+ T follicular helper cells is linked to IgG4 class switching in vivo", Life Sci Alliance, 1, pp.e201800050~ (2018)
  53. Wallace ZS, "Ophthalmic manifestations of IgG4-related disease : single-center experience and literature review", Semin Arthritis Rheum, 43, pp.806~817 (2014)
  54. Baer AN, "Rare diagnosis of IgG4-related systemic disease by lip biopsy in an international Sjögren syndrome registry", Oral Surg Oral Med Oral Pathol Oral Radiol, 115, pp.e34~e39 (2013)
  55. Yamamoto M, "Clinical and pathological characteristics of Mikulicz's disease(IgG4-related plasmacytic exocrinopathy)", Autoimmun Rev, 4, pp.195~200 (2005)
  56. Hu EK, "Immunoglobulin G4-related disease presenting as an ethmoid and maxillary mass", Ann Allergy Asthma Immunol, 111, pp.75~77 (2013)
  57. Dahlgren M, "Riedel's thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum", Arthritis Care Res(Hoboken), 62, pp.1312~1318 (2010)
  58. Cheuk W, "Lymphadenopathy of IgG4-related disease : an underdiagnosed and overdiagnosed entity", Semin Diagn Pathol, 29, pp.226~234 (2012)
  59. Stone JH, "IgG4-related disease", N Engl J Med, 366, pp.539~551 (2012)
  60. Khosroshahi A, "Rethinking Ormond's disease: "idiopathic"retroperitoneal fibrosis in the era of IgG4-related disease", Medicine (Baltimore), 92, pp.82~91 (2013)
  61. Inoue D, "Immunoglobulin G4-related lung disease : CT findings with pathologic correlations", Radiology, 251, pp.260~270 (2009)
  62. Saeki T, "Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis", Kidney Int, 78, pp.1016~1023 (2010)
  63. Stone JH, "Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations", Arthritis Rheum, 64, pp.3061~3067 (2012)
  64. Zen Y, "IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis?", Am J Surg Pathol, 28, pp.1193~1203 (2004)
  65. Mattoo H, "Circulating Th2 memory cells in IgG4-related disease are restricted to a defined subset of subjects with atopy", Allergy, 69, pp.399~402 (2014)
  66. Maehara T, "Interleukin-21 contributes to germinal centre formation and immunoglobulin G4 production in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz's disease", Ann Rheum Dis, 71, pp.2011~2019 (2012)
  67. Akiyama M, "Follicular helper T cells in the pathogenesis of IgG4-related disease", Rheumatology(Oxford), 57, pp.236~245 (2018)
  68. Kamekura R, "Cutting edge : a critical role of lesional T follicular helper cells in the pathogenesis of IgG4-related disease", J Immunol, 199, pp.2624~2629 (2017)
  69. Kamekura R, "Circulating PD-1+CXCR5-CD4+ T cells underlying the immunological mechanisms of IgG4-related disease", Rheumatol Adv Pract, 2 (2018)
  70. Perugino CA, "Identification of galectin-3 as an autoantigen in patients with IgG4-related disease", J Allergy Clin Immunol, 143, pp.736~745 (2019)
  71. Shiokawa M, "Pathogenicity of IgG in patients with IgG4-related disease", Gut, 65, pp.1322~1332 (2016)
  72. Furukawa S, "Preferential M2 macrophages contribute to fibrosis in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz's disease", Clin Immunol, 156, pp.9~18 (2015)
  73. Ohta M, "DNA microarray analysis of submandibular glands in IgG4-related disease indicates a role for MARCO and other innate Immune-related proteins", Medicine (Baltimore), 95, pp.e2853~ (2016)
  74. Perugino CA, "Treatment of IgG4-related disease : current and future approaches", Z Rheumatol, 75, pp.681~686 (2016)
  75. Perugino CA, "Emerging treatment models in rheumatology : IgG4-related disease : insights into human immunology and targeted therapies", Arthritis Rheumatol, 69, pp.1722~1732 (2017)

관련 논문AI추천

이 간행물의 다른 논문 (12건)